"Drug Resistance, Fungal" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The ability of fungi to resist or to become tolerant to chemotherapeutic agents, antifungal agents, or antibiotics. This resistance may be acquired through gene mutation.
| Descriptor ID |
D025141
|
| MeSH Number(s) |
G06.225.383 G07.690.773.984.269.383
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Drug Resistance, Fungal".
Below are MeSH descriptors whose meaning is more specific than "Drug Resistance, Fungal".
This graph shows the total number of publications written about "Drug Resistance, Fungal" by people in this website by year, and whether "Drug Resistance, Fungal" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2006 | 1 | 0 | 1 |
| 2007 | 0 | 1 | 1 |
| 2009 | 3 | 0 | 3 |
| 2013 | 2 | 1 | 3 |
| 2014 | 1 | 2 | 3 |
| 2016 | 1 | 3 | 4 |
| 2017 | 13 | 26 | 39 |
| 2018 | 22 | 24 | 46 |
| 2019 | 8 | 5 | 13 |
| 2020 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Drug Resistance, Fungal" by people in Profiles.
-
Genomic Diversity of Azole-Resistant Aspergillus fumigatus in the United States. mBio. 2021 08 31; 12(4):e0180321.
-
Kinetic characterisation and inhibitor sensitivity of Candida albicans and Candida auris recombinant AOX expressed in a self-assembled proteoliposome system. Sci Rep. 2021 07 20; 11(1):14748.
-
Aspergillosis: Epidemiology, Diagnosis, and Treatment. Infect Dis Clin North Am. 2021 06; 35(2):415-434.
-
Coronavirus disease and candidemia infection: A case report. J Mycol Med. 2021 Sep; 31(3):101155.
-
Geospatial Spread of Antimicrobial Resistance, Bacterial and Fungal Threats to Coronavirus Infectious Disease 2019 (COVID-19) Survival, and Point-of-Care Solutions. Arch Pathol Lab Med. 2021 02 01; 145(2):145-167.
-
Isavuconazole for the treatment of patients with invasive fungal diseases involving the central nervous system. Med Mycol. 2020 Jun 01; 58(4):417-424.
-
Prevalence of voriconazole-resistant invasive aspergillosis and its impact on mortality in haematology patients. J Antimicrob Chemother. 2019 09 01; 74(9):2759-2766.
-
Candida auris: An Emerging Antimicrobial Resistance Threat. Ann Intern Med. 2019 09 17; 171(6):432-433.
-
Candida auris: a comparison between planktonic and biofilm susceptibility to antifungal drugs. J Med Microbiol. 2019 Sep; 68(9):1353-1358.
-
A case report of fungemia due to Kodamaea ohmeri. BMC Infect Dis. 2019 Jul 01; 19(1):570.